Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.brawnbiotech.com | |
Market Cap | 5.83 Cr. | |
Enterprise Value(EV) | 5.83 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.13 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.75 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 19.03 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 1.02 | Calculated using Price: 19.42 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.30 Cr. | 3,000,300 Shares |
FaceValue | 10 | |
About Brawn Biotech Ltd. | ||
Brawn Pharmaceuticals was incorporated in the year 1985 it operates in health care sector in India and outside India. It has started its business by selling pharmaceutical formulations manufactured by other company's loan license basis. The company is located in New Delhi, India. |
1 Day |
|
+4.97% |
1 Week |
|
+7.59% |
1 Month |
|
+19.14% |
3 Month |
|
-18.81% |
6 Month |
|
+18.49% |
1 Year |
|
+6.70% |
2 Year |
|
+0.10% |
5 Year |
|
-53.49% |
10 Year |
|
+231.40% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 5.91 | 18.15 | 22.39 | 17.62 | 16.37 | 6.60 | -6.10 | -20.53 | -12.83 | |
Return on Capital Employed (%) | 11.98 | 26.39 | 29.04 | 27.75 | 23.03 | 9.74 | -3.57 | -25.66 | -5.94 | |
Return on Assets (%) | 2.05 | 6.80 | 9.01 | 6.49 | 5.93 | 2.77 | -3.24 | -12.23 | -6.31 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 5 | 6 | 7 | 8 | 9 | 9 | 9 | 7 | 6 | 6 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Curr. Liab. | 9 | 8 | 10 | 15 | 14 | 11 | 5 | 6 | 8 | 5 | |
Minority Int. | |||||||||||
Equity & Liab. | 14 | 14 | 17 | 22 | 22 | 20 | 14 | 13 | 14 | 12 | |
Non Curr. Assets | 3 | 3 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | |
Curr. Assets | 11 | 11 | 17 | 22 | 22 | 19 | 13 | 12 | 13 | 11 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 14 | 14 | 17 | 22 | 22 | 20 | 14 | 13 | 14 | 12 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 39 | 47 | 61 | 56 | 65 | 50 | 35 | 9 | 22 | 21 | |
Other Income | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | ||
Total Income | 39 | 47 | 61 | 56 | 66 | 50 | 35 | 9 | 22 | 21 | |
Total Expenditure | -38 | -45 | -59 | -54 | -64 | -49 | -36 | -11 | -23 | -22 | |
PBIDT | 1 | 1 | 2 | 2 | 2 | 1 | 0 | -2 | 0 | -1 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 1 | 1 | 1 | 1 | 1 | -1 | -2 | -1 | -1 | |
Adjusted EPS | 1 | 3 | 5 | 4 | 4 | 2 | -2 | -5 | -3 | -4 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 1 | -2 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | ||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | 2 | -2 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
Thu, 16 Nov 2023
Non Applicability For Filing Of Related Party Disclosures The confirmation for filing of non applicability of related party transactions for the quarter/half year ended 30/09/2023. |
Sat, 11 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication NEWSPAPER PUBLICATION OF RESULTS FOR THE QUARTER /HALF YEAR ENDED 30TH SEPTEMBER 2023. |
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting The Board of the Company at its meeting held today 10th November 2023 has considered and approved the Un-audited Financial Results for the quarter and half year ended on September 30 2023. A copy of the said results along with Limited Review Reports issued by the Auditor is enclosed herewith. The aforesaid Board Meeting Commenced at 01:00 P.M. (IST) and concluded at 01:30 P.M. (IST). |
Fri, 01 Dec 2023 |
|
|
|
|
|